Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy

Heart

Volumn 96, Issue 14, 2010, Pages 1137-1141

  Cheung, Yiu Fai ^a   Hong, Wen Jing ^a   Chan, Godfrey C F ^a   Wong, Sophia J ^a   Ha, Shau Yin ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; DAUNORUBICIN; DOXORUBICIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MECHANICAL DYSSYNCHRONY; HEART LEFT VENTRICLE MYOCARDIAL DEFORMATION; HEART LEFT VENTRICLE VOLUME; HUMAN; MALE; MYOCARDIAL DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; FEMALE; HUMANS; MALE; MYOCARDIAL CONTRACTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 77954443491     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.194118     Document Type: Article

References (32)

1. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991;324:808-15.
2. Lipshultz SE, Lipsitz SR, Mone SM, et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 1995;332:1738-43.
3. Lipshultz SE, Lipsitz SR, Sallan SE, et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 2005;23:2629-36.
4. van Dalen EC, van den Brug M, Caron HN, et al. Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials. Eur J Cancer 2006;42:3199-205.
5. Elbl L, Hrstkova H, Tomaskova I, et al. Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients. Eur J Pediatr 2005;164:678-84.
6. Arita T, Sorescu GP, Schuler BT, et al. Speckle-tracking strain echocardiography for detecting cardiac dyssynchrony in a canine model of dyssynchrony and heart failure. Am J Physiol Heart Circ Physiol 2007;293:H735-42.
7. Kapusta L, Groot-Loonen J, Thijssen JM, et al. Regional cardiac wall motion abnormalities during and shortly after anthracycline therapy. Med Pediatr Oncol 2003;41:426-35.
8. Leitman M, Lysyansky P, Sidenko S, et al. Two-dimensional strain - a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 2004;17:1021-9.
9. Kapetanakis S, Kearney MT, Siva A, et al. Real-time three-dimensional echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony. Circulation 2005;112:992-1000.
10. Cheung EW, Liang XC, Lam WW, et al. Impact of right ventricular dilation on left ventricular myocardial deformation in patients after surgical repair of tetralogy of Fallot. Am J Cardiol 2009;104:1264-70.
11. Chow PC, Liang XC, Cheung EW, et al. New two-dimensional global longitudinal strain and strain rate imaging for assessment of systemic right ventricular function. Heart 2008;94:855-9.
12. Mavinkurve-Groothuis AM, Weijers G, Groot-Loonen, et al. Interobserver, intraobserver and intrapatient reliability scores of myocardial strain imaging with 2-D echocardiography in patients treated with anthracyclines. Ultrasound Med Biol 2009;35:697-704.
13. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
14. Liang XC, Cheung EW, Wong SJ, et al. Impact of right ventricular volume overload on three-dimensional global left ventricular mechanical dyssynchrony after surgical repair of tetralogy of Fallot. Am J Cardiol 2008;102:1731-6.
15. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83. (Pubitemid 9091990)
16. Lipshultz SE, Easley KA, Orav EJ, et al. Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P(2)C(2) HIV study. Circulation 2001;104:310-16.
17. Greenberg NL, Firstenberg MS, Castro PL, et al. Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation 2002;105:99-105.
18. Pellerin D, Sharma R, Elliott P, et al. Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 2003;89(Suppl 3):iii9-17.
19. Weidemann F, Jamal F, Kowalski M, et al. Can strain rate and strain quantify changes in regional systolic function during dobutamine infusion, B-blockade, and atrial pacing - implications for quantitative stress echocardiography. J Am Soc Echocardiogr 2002;15:416-24.
20. Weidemann F, Jamal F, Sutherland GR, et al. Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate. Am J Physiol Heart Circ Physiol 2002;283:H792-9.
21. Ganame J, Claus P, Uyttebroeck A, et al. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients. J Am Soc Echocardiogr 2007;20:1351-8.
22. Marwick TH. Measurement of strain and strain rate by echocardiography: ready for prime time? J Am Coll Cardiol 2006;47:1313-27.
23. Ng AC, Tran da T, Newman M, et al. Comparison of myocardial tissue velocities measured by two-dimensional speckle tracking and tissue Doppler imaging. Am J Cardiol 2008;102:784-9.
24. Amundsen BH, Helle-Valle T, Edvardsen T, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol 2006;47:789-93.
25. Tanaka H, Oishi Y, Mizuguchi Y, et al. Three-dimensional evaluation of dobutamine-induced changes in regional myocardial deformation in ischemic myocardium using ultrasonic strain measurements: the role of circumferential myocardial shortening. J Am Soc Echocardiogr 2007;20:1294-9.
26. Jones BO, Davis AM, Alison J, et al. Cardiac re-synchronization therapy in a child with severe anthracycline-induced congestive heart failure and normal QRS duration. J Heart Lung Transplant 2007;26:1333-5.
27. Ahlehoff O, Galloe AM, Hansen PR. Anthracycline-induced cardiomyopathy: favourable effects of cardiac resynchronization therapy. Int J Cardiol. Published Online First: 8 Jan 2009. doi: 10.1016/j.ijcard.2008.11.194.
28. Ajijola OA, Nandigam KV, Chabner BA, et al. Usefulness of cardiac resynchronization therapy in the management of doxorubicin-induced cardiomyopathy. Am J Cardiol 2008;101:1371-2.
29. Takemura G, Fujiwara H. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 2007;49:330-52. (Pubitemid 46295436)
30. Psaltis PJ, Carbone A, Nelson AJ, et al. An ovine model of anthracycline-induced cardiotoxicity - applicability as a pre-clinical surrogate for nonischaemic cardiomyopathy. Heart Lung Circ 2009;18S:S169.
31. Perel RD, Slaughter RE, Strugnell WE. Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma. J Cardiovasc Magn Reson 2006;8:789-91.
32. Sorensen K, Levitt G, Sebag-Monteflore D, et al. Cardiac function in Wilm's tumor survivors. J Clin Oncol 1995;13:1546-56.